ID

21998

Description

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00452803

Lien

https://clinicaltrials.gov/show/NCT00452803

Mots-clés

Versions (1)
  1. 14/05/2017 14/05/2017 -
Téléchargé le

14 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lung Cancer NCT00452803

Anglais

Eligibility Lung Cancer NCT00452803

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologic or cytologic diagnosis of non-small cell lung cancer.
Description

nsclc

Type de données

boolean

Alias
UMLS CUI [1]
C0007131
2. presence of biopsy-proven n2 stage iiia, according to the american joint committee on cancer (ajcc), with none of the mediastinal lymph nodes > 3 cm in largest diameter.
Description

nsclc ajcc stage, mediastinal lymph nodes

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C0441915
UMLS CUI [1,4]
C0449393
3. tumor amenable to surgical resection.
Description

tumor amenable to surgical resection

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C3900053
UMLS CUI [1,3]
C0728940
4. at least one unidimensional measurable lesion meeting response evaluation criteria in solid tumors (recist. 2000).
Description

response evaluation criteria in solid tumors

Type de données

boolean

Alias
UMLS CUI [1]
C1709926
5. no prior tumor therapy (surgery, radiotherapy, chemotherapy, immunotherapy, or any other type of tumor therapy).
Description

prior tumor therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C1514463
6. performance status of 0-1 on ecog scale.
Description

ecog

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
7. at least 18 years old.
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
8. patient compliance that allows adequate follow-up.
Description

follow-up compliance

Type de données

boolean

Alias
UMLS CUI [1,1]
C3274571
UMLS CUI [1,2]
C1321605
9. medical fitness of patients adequate for radical nsclc surgery.
Description

patient condition, radical nsclc surgery

Type de données

boolean

Alias
UMLS CUI [1,1]
C0683521
UMLS CUI [1,2]
C0007131
UMLS CUI [1,3]
C0543467
UMLS CUI [1,4]
C0439807
10. adequate organ function including the following:adequate hematologic function: wbc count ≥ 4,000/ul, absolute neutrophil count (anc) ≥ 1,500/ul, platelet count ≥ 100,000/ul, and hemoglobin ≥ 10 gm/dl.adequate hepatic function: bilirubin ≤ 1.5 x unl, alt or ast ≤ 2.5 x unl.adequate renal function: creatinine ≤ 1.5mg/dl.
Description

hematologic, hepatic, renal function

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0948762
UMLS CUI [1,3]
C0005821
UMLS CUI [1,4]
C0019046
UMLS CUI [2,1]
C0232741
UMLS CUI [2,2]
C1278039
UMLS CUI [2,3]
C0201899
UMLS CUI [2,4]
C0201836
UMLS CUI [3,1]
C0232804
UMLS CUI [3,2]
C0201976
11. signed informed consent from patient or legal representative.
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
12. patients with reproductive potential must use an approved contraceptive method during and for 3 months after the study. females with childbearing potential must have a negative urine hcg test within 7 days prior to study enrollment.
Description

effective contraception, pregnancy test

Type de données

text

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C0032976
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. concurrent administration of any other tumor therapy, including radiotherapy, chemotherapy, immunotherapy.
Description

concurrent tumor therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0920425
2. active uncontrolled infection.
Description

uncontrolled infection

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
3. serious concomitant disorders that would compromise the safety of patient or compromise the patient's ability to tolerate therapy.
Description

comorbidities

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
4. mi within preceding 6 months or symptomatic heart disease including unstable angina, congestive heart failure, or uncontrolled arrhythmia.
Description

heart diseases

Type de données

boolean

Alias
UMLS CUI [1]
C0018799
5. significant neurological or mental disorder.
Description

neurological or mental disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0004936
6. second primary malignancy.
Description

second primary malignancy

Type de données

boolean

Alias
UMLS CUI [1]
C0751623
7. pregnant or nursing.
Description

pregnancy, breast feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Lung Cancer NCT00452803

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
nsclc
Item
1. histologic or cytologic diagnosis of non-small cell lung cancer.
boolean
C0007131 (UMLS CUI [1])
nsclc ajcc stage, mediastinal lymph nodes
Item
2. presence of biopsy-proven n2 stage iiia, according to the american joint committee on cancer (ajcc), with none of the mediastinal lymph nodes > 3 cm in largest diameter.
boolean
C0007131 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C0441915 (UMLS CUI [1,3])
C0449393 (UMLS CUI [1,4])
tumor amenable to surgical resection
Item
3. tumor amenable to surgical resection.
boolean
C0006826 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C0728940 (UMLS CUI [1,3])
response evaluation criteria in solid tumors
Item
4. at least one unidimensional measurable lesion meeting response evaluation criteria in solid tumors (recist. 2000).
boolean
C1709926 (UMLS CUI [1])
prior tumor therapy
Item
5. no prior tumor therapy (surgery, radiotherapy, chemotherapy, immunotherapy, or any other type of tumor therapy).
boolean
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
ecog
Item
6. performance status of 0-1 on ecog scale.
boolean
C1520224 (UMLS CUI [1])
age
Item
7. at least 18 years old.
boolean
C0001779 (UMLS CUI [1])
follow-up compliance
Item
8. patient compliance that allows adequate follow-up.
boolean
C3274571 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
patient condition, radical nsclc surgery
Item
9. medical fitness of patients adequate for radical nsclc surgery.
boolean
C0683521 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,3])
C0439807 (UMLS CUI [1,4])
hematologic, hepatic, renal function
Item
10. adequate organ function including the following:adequate hematologic function: wbc count ≥ 4,000/ul, absolute neutrophil count (anc) ≥ 1,500/ul, platelet count ≥ 100,000/ul, and hemoglobin ≥ 10 gm/dl.adequate hepatic function: bilirubin ≤ 1.5 x unl, alt or ast ≤ 2.5 x unl.adequate renal function: creatinine ≤ 1.5mg/dl.
boolean
C0221130 (UMLS CUI [1,1])
C0948762 (UMLS CUI [1,2])
C0005821 (UMLS CUI [1,3])
C0019046 (UMLS CUI [1,4])
C0232741 (UMLS CUI [2,1])
C1278039 (UMLS CUI [2,2])
C0201899 (UMLS CUI [2,3])
C0201836 (UMLS CUI [2,4])
C0232804 (UMLS CUI [3,1])
C0201976 (UMLS CUI [3,2])
informed consent
Item
11. signed informed consent from patient or legal representative.
boolean
C0021430 (UMLS CUI [1])
effective contraception, pregnancy test
Item
12. patients with reproductive potential must use an approved contraceptive method during and for 3 months after the study. females with childbearing potential must have a negative urine hcg test within 7 days prior to study enrollment.
text
C0700589 (UMLS CUI [1])
C0032976 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
concurrent tumor therapy
Item
1. concurrent administration of any other tumor therapy, including radiotherapy, chemotherapy, immunotherapy.
boolean
C0009429 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
uncontrolled infection
Item
2. active uncontrolled infection.
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
comorbidities
Item
3. serious concomitant disorders that would compromise the safety of patient or compromise the patient's ability to tolerate therapy.
boolean
C0009488 (UMLS CUI [1])
heart diseases
Item
4. mi within preceding 6 months or symptomatic heart disease including unstable angina, congestive heart failure, or uncontrolled arrhythmia.
boolean
C0018799 (UMLS CUI [1])
neurological or mental disorder
Item
5. significant neurological or mental disorder.
boolean
C0027765 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
second primary malignancy
Item
6. second primary malignancy.
boolean
C0751623 (UMLS CUI [1])
pregnancy, breast feeding
Item
7. pregnant or nursing.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial